Dabur India Ltd Q4 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/kccfinhro65xj3tnih1hcm5g.pdf

Key Takeaways


The Deliberate Inventory Reset

Mohit Malhotra: "Had we loaded once again, then there was no point of doing any kind of inventory correction, we would have gone back to around the same level of unhygienic inventory. So we did not do that."

Strategy Refresh: Premiumization & Portfolio Rationalization

Mohit Malhotra: "If you look at past 4 to 5 years, we've generally focused on increasing market share and consolidating our business in each of the categories. But premiumisation has been lesser focus and it was a deliberate attempt... Now that we've done all the gain market shares... now it's 2.0 journey to embark upon premiumisation and contemporisation."

Category-Level Performance

CategoryTrendCommentary
Skincare▲ GrowthGrew 8% driven by Gulabari.
Home Care▬ Low single-digitOdonil performed well; Odomos impacted by unfavorable seasonality but gained 386 bps market share.
Oral Care▼ Sequentially downDown 10%-12% QoQ on a 22% prior-year base; all brands gaining share, IDA certification received, court case won.
Hair Oils▬ MixedShampoo grew ~4%; Hair Oils grew ahead of category with 196 bps share gain; Coconut Hair Oil grew 11%.
Health Supplements▼ MutedHoney and Chyawanprash hit by delayed and contracted winters, though both gained share (162 bps and 75 bps). Glucose grew 10%.
Digestives▲ Modest growthHajmola franchise grew 3.3% with 233 bps share gain; Hajmola Zeera launch well received.
Health Juices▲ StrongGrew 25% YoY.
Culinary▲ StrongGrew 14% led by Hommade; Badshah grew 6% in Q4 (institutional sales hit by CSD budget cuts) but 12% for FY25.
Beverages▼ ImpactedUrban consumption slowdown (70% of portfolio is urban); premium segment did well with Real Activ and coconut water growing 11%; 261 bps share gain in J&N category.
International▲ Robust19% CC growth driven by MENA, Egypt, UK, USA, Turkey, and Bangladesh.

Gross Margin Pressure & Pricing Dynamics

Mohit Malhotra: "there will be specific guardrails where every new product launch will have to have an accretive margin to the core product of it. And therefore, it will lift the overall gross margin profile."

GTM Overhaul & Channel Strategy


M&A, Compliance & Adjacent Bets

Mohit Malhotra: "we are very reluctant to use recycled plastic in food products and also in our Ayurvedic product. Like in pharmaceutical industry, you don't use recycled plastic. So we are reluctant."

Guidance & Commitments

CommitmentSpecificsTimeline
FY26 revenue growthHigh single-digit, if not double-digit or near double-digit value growth; sequential improvement expected after Q1 laps a 7% baseFY26 full year
FY28 ambitionSustainable double-digit CAGR in both top line and bottom lineBy FY28
Beverage growthLow to mid-single digit for the beverage portfolioFY26
Premiumization journeyBegins from current quarter; every new product launch to have accretive margin to core productStarting Q1 FY26
Portfolio exitsExit tea, baby diapers, sanitizing category, and Vita (less than 1% of revenue)No date (underway)
Therapeutics scale-upGrow from INR100 crore to INR200 crore turnoverNo date given
GTM rekindlementUrban stockist consolidation and rural expansion beginStarting current year

Key Metrics

MetricQ4 FY25
Consolidated revenue₹12,563 cr (FY25), +3.6% YoY in constant currency
Consolidated revenue growth+2.1% in constant currency, +0.6% in INR terms YoY
PAT₹1,768 cr (FY25)
India business revenue growth-3.4% YoY
International business revenue growth+19.3% in constant currency YoY
Standalone India gross margin contraction~247 bps YoY, driven by 4.5%–5% inflation vs 3.5% price increase
Overall price increase taken~3.5%, to flow through to Q1 FY26
FY26 revenue growth guidanceHigh single-digit to near double-digit value growth for full year
Rural tertiary growth (Nielsen)13%–14% YoY, ahead of urban
Rural vs urban growth gapRural growing ~450 bps ahead of urban India
Inventory days correctionReduced from 30 days to 21 days
Skincare growth+8% YoY, driven by Gulabari
Oral Care prior-year base+22% YoY in Q4 FY24
Oral Care market share gain15–16 bps in Q4
Hair Oils market share gain196 bps
Coconut Hair Oil growth+11% YoY
Glucose growth+10% YoY, market share gain of 112 bps
Hajmola franchise growth+3.3% YoY, market share gain of 233 bps
Dabur Health Juices growth+25% YoY
Culinary business growth+14% YoY, led by Hommade
Badshah growth+6% YoY in Q4, +12% in FY25
Real Activ and coconut water growth+11% YoY
J&N category market share gain261 bps
Odomos market share gain386 bps in MRC category
Odonil market share gain67 bps
Chyawanprash market share gain162 bps
Honey market share gain75 bps
Dabur Amla market share19.1%, all-time high, up from ~14% three years ago
Beverage loading reduction~₹50–60 cr less primary loading in season
Primary sales-3% YoY (approx.)
Secondary sales+5% YoY (approx.)
Categories identified for exitTea, baby diapers, Vita, breakfast cereals; contribute less than 1% of revenue
Food inflation2%–2.5%
Q1 FY25 base growth~7% YoY
Health Care CAGR7%–8%
Beverages CAGR10%+
Odomos CAGR8%–10%
Oral Care CAGR9%–10%
Meswak growth10%–11% YoY
Herbal category share in modern trade~31%, up from 30% last year
Therapeutics business targetFrom ₹100 cr to ₹200 cr turnover
Medical practitioners addressed (therapeutics)~100,000
Brands of ₹500 cr+8 brands, contributing ~70% of portfolio
Hajmola extensions and variants contribution>15% of Hajmola franchise
RPI vs ColasBrought down to ₹99 price point, from 2.2–2.7 index
MGNREGA outlay increase+40% in rural India